Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2022) 81 P767 | DOI: 10.1530/endoabs.81.P767

ECE2022 Poster Presentations Late-Breaking (41 abstracts)

Correlation of adiponectin and resistin with atherogenic markers in insulin resistant and non-insulin resistant adolescent women with polycystic ovary syndrome

Aleksandra Atanasova Boshku & Daniela Ivanova Panova


University Clinic of Gynecology and Obstetrics, Faculty of Medicine, Ss. Cyril and Methodius University Skopje, Skopje, North Macedonia


Aim: To evaluate adiponectin and resistin levels and their relationship with various biochemical and metabolic and atherogenic parameters markers, as well as their correlation, and to investigate its contribution in pathogenesis of insulin resistance in cohort women with PCOS and of insulin resistance as well as in non-insulin resistant women with PCOS. Methods: This study was designed as a cross-sectional and involves 80 premenopausal women. Of these patients, 63 females have met the criteria for PCOS (59 insulin resistant, 28 non-insulin resistant). We assessed anthropometric indices of obesity –waist and hip circumference, waist to hip ratio, serum glucose, insulin, total cholesterol, HDL-cholesterol, triglycerides, FSH, LH, E2, testosterone, adiponectin and resistin. Body mass index, waist to hip ratio, HOMA-IR, LDL-cholesterol, and adiponectin to resistin ratio were calculated. Results: Insulin resistant PCOS woman had significantly lower levels of adiponectin compared to non-insulin resistant PCOS women, and controls. Resistin levels were higher in IR-PCOS, but without statistical significance. Adiponectin showed significant positive correlation with LH, HDL-C, and negative correlation with BMI, insulin, HOMA-IR and triglycerides. Resistin correlated positively with BMI and WC. A/R was significantly higher in insulin resistant PCOS women compared to non-insulin resistant and control women. Conclusions: These results suggest that PCOS women were at higher metabolic and atherogenic risk as compared to the healthy women, and also more pronounced in the insulin-resistant group. Correlations of adipokines with insulin resistance suggest their involvement of adipokines in modulation of insulin action in PCOS women.

Volume 81

European Congress of Endocrinology 2022

Milan, Italy
21 May 2022 - 24 May 2022

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

Authors